- Home
- DTI vs GALT Comparison
DTI vs GALT Comparison
Compare DTI & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTI
- GALT
- Stock Information
- Founded
- DTI 1984
- GALT 2000
- Country
- DTI United States
- GALT United States
- Employees
- DTI N/A
- GALT N/A
- Industry
- DTI Metal Fabrications
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- DTI Industrials
- GALT Health Care
- Exchange
- DTI Nasdaq
- GALT Nasdaq
- Market Cap
- DTI 82.6M
- GALT 83.5M
- IPO Year
- DTI N/A
- GALT N/A
- Fundamental
- Price
- DTI $2.22
- GALT $2.91
- Analyst Decision
- DTI Strong Buy
- GALT Buy
- Analyst Count
- DTI 1
- GALT 2
- Target Price
- DTI $5.50
- GALT $6.00
- AVG Volume (30 Days)
- DTI 133.8K
- GALT 411.0K
- Earning Date
- DTI 08-05-2025
- GALT 08-12-2025
- Dividend Yield
- DTI N/A
- GALT N/A
- EPS Growth
- DTI N/A
- GALT N/A
- EPS
- DTI N/A
- GALT N/A
- Revenue
- DTI $160,352,000.00
- GALT N/A
- Revenue This Year
- DTI $2.22
- GALT N/A
- Revenue Next Year
- DTI $2.11
- GALT N/A
- P/E Ratio
- DTI N/A
- GALT N/A
- Revenue Growth
- DTI 8.19
- GALT N/A
- 52 Week Low
- DTI $1.43
- GALT $0.73
- 52 Week High
- DTI $5.80
- GALT $3.90
- Technical
- Relative Strength Index (RSI)
- DTI 32.44
- GALT 65.45
- Support Level
- DTI $2.25
- GALT $2.54
- Resistance Level
- DTI $2.39
- GALT $3.15
- Average True Range (ATR)
- DTI 0.16
- GALT 0.23
- MACD
- DTI -0.03
- GALT 0.00
- Stochastic Oscillator
- DTI 7.79
- GALT 75.68
About DTI Drilling Tools International Corporation
Drilling Tools International Corp manufactures, rents, inspects, and refurbishes downhole drilling tools primarily to companies in the oil and natural gas industry for bottom hole assemblies used in onshore and offshore horizontal and directional drilling. The company's United States operations have locations in Texas, California, Louisiana, Oklahoma, Pennsylvania, North Dakota, New Mexico, Utah, and Wyoming. The company's single segment derives revenues from customers by providing oilfield equipment and services to operators in the oil and natural gas sectors.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.